Literature DB >> 26547198

Administration of the Glial Condition Medium in the Nucleus Accumbens Prolong Maintenance and Intensify Reinstatement of Morphine-Seeking Behavior.

Reza Arezoomandan1, Fariba Khodagholi1, Abbas Haghparast2.   

Abstract

Accumulating evidence suggested that glial cells are involved in synaptic plasticity and behavioral changes induced by drugs abuse. The role of these cells in maintenance and reinstatement of morphine (MRP) conditioned place preference (CPP) remains poorly characterized. The aim of present study was to investigate the direct role of glial cells in nucleus accumbens (NAc) in the maintenance and reinstatement of MRP-seeking behavior. CPP induced with injection of MRP (5 mg/kg, s.c. for 3 days), lasted for 7 days after cessation of MRP treatment and priming dose of MRP (1 mg/kg, s.c.) reinstated the extinguished MRP-induced CPP. The astrocyte-conditioned medium (ACM) and neuroglia conditioned medium (NCM) exposed to MRP (10 and 100 µM) have been microinjected into the NAc. Intra-NAc administration of ACM during extinction period failed to change the maintenance of MRP-CPP, but MRP 100-treated ACM could slightly increase the magnitude of reinstatement. In contrast to ACM, intra-NAc administration of MRP 100-treated NCM caused slower extinction by 3 days and significantly increased the magnitude of reinstatement. Our findings suggest the involvement of glial cells activation in the maintenance and reinstatement of MRP-seeking behaviors, and provides new evidence that these cells might be a potential target for the treatment of MRP addiction.

Entities:  

Keywords:  Conditioned place preference; Extinction; Glial cell; Morphine; Nucleus accumbens; Reinstatement

Mesh:

Substances:

Year:  2015        PMID: 26547198     DOI: 10.1007/s11064-015-1762-3

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  43 in total

Review 1.  Immune function of astrocytes.

Authors:  Y Dong; E N Benveniste
Journal:  Glia       Date:  2001-11       Impact factor: 7.452

2.  Culture of neonatal rodent microglia, astrocytes, and oligodendrocytes from cortex and spinal cord.

Authors:  Stephen D Skaper; Carla Argentini; Massimo Barbierato
Journal:  Methods Mol Biol       Date:  2012

3.  The involvement of glial cells in the development of morphine tolerance.

Authors:  P Song; Z Q Zhao
Journal:  Neurosci Res       Date:  2001-03       Impact factor: 3.304

Review 4.  Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning.

Authors:  F Mennicken; R Maki; E B de Souza; R Quirion
Journal:  Trends Pharmacol Sci       Date:  1999-02       Impact factor: 14.819

5.  Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse.

Authors:  Minoru Narita; Mayumi Miyatake; Michiko Narita; Masahiro Shibasaki; Keiko Shindo; Atsushi Nakamura; Naoko Kuzumaki; Yasuyuki Nagumo; Tsutomu Suzuki
Journal:  Neuropsychopharmacology       Date:  2006-01-11       Impact factor: 7.853

6.  Protein phosphorylation cascades associated with methamphetamine-induced glial activation.

Authors:  M A Hebert; J P O'Callaghan
Journal:  Ann N Y Acad Sci       Date:  2000-09       Impact factor: 5.691

7.  Morphine-induced chemotaxis and brain-derived neurotrophic factor expression in microglia.

Authors:  Naoko Takayama; Hiroshi Ueda
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

8.  Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area.

Authors:  D Beitner-Johnson; X Guitart; E J Nestler
Journal:  J Neurochem       Date:  1993-11       Impact factor: 5.372

9.  Nitric oxide within the ventral tegmental area is involved in mediating morphine reward.

Authors:  Azam Gholami; Mohammad Reza Zarrindast; Hedayat Sahraei; Ali Haerri-Rohani
Journal:  Eur J Pharmacol       Date:  2003-01-01       Impact factor: 4.432

10.  The roles of glial cell line-derived neurotrophic factor, tumor necrosis factor-alpha, and an inducer of these factors in drug dependence.

Authors:  Minae Niwa; Atsumi Nitta; Kiyofumi Yamada; Toshitaka Nabeshima
Journal:  J Pharmacol Sci       Date:  2007-05-31       Impact factor: 3.337

View more
  5 in total

1.  Removal of microglial-specific MyD88 signaling alters dentate gyrus doublecortin and enhances opioid addiction-like behaviors.

Authors:  Phillip D Rivera; Richa Hanamsagar; Matthew J Kan; Phuong K Tran; David Stewart; Young Chan Jo; Michael Gunn; Staci D Bilbo
Journal:  Brain Behav Immun       Date:  2018-11-15       Impact factor: 7.217

Review 2.  Glial neuroimmune signaling in opioid reward.

Authors:  Hong Zhang; Tally M Largent-Milnes; Todd W Vanderah
Journal:  Brain Res Bull       Date:  2019-11-29       Impact factor: 4.077

3.  The role of gut-immune-brain signaling in substance use disorders.

Authors:  Kelsey E Lucerne; Drew D Kiraly
Journal:  Int Rev Neurobiol       Date:  2020-10-24       Impact factor: 4.280

4.  Co-occurrence of preconception maternal childhood adversity and opioid use during pregnancy: Implications for offspring brain development.

Authors:  Madeleine C Allen; Nora K Moog; Claudia Buss; Elizabeth Yen; Hanna C Gustafsson; Elinor L Sullivan; Alice M Graham
Journal:  Neurotoxicol Teratol       Date:  2021-09-30       Impact factor: 4.071

Review 5.  A Glitch in the Matrix: The Role of Extracellular Matrix Remodeling in Opioid Use Disorder.

Authors:  Madelyn H Ray; Benjamin R Williams; Madeline K Kuppe; Camron D Bryant; Ryan W Logan
Journal:  Front Integr Neurosci       Date:  2022-06-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.